Drug Companies Spend Record On Lobbying

Law360, New York (April 3, 2007, 12:00 AM EDT) -- Health companies spent $182 million lobbying Capitol Hill between January 2005 and June 2006, setting a record as they weighed in on issues from drug prices to drug safety, a public interest group has found.

Drug makers shelled out the bulk of that sum, spending $155 million and hiring 1,100 lobbyists to fight for such issues as keeping cheaper Canadian pharmaceuticals out of the country and protecting lucrative drug patents, a study by the Center for Public Integrity said.

Pharmaceutical companies “have been facing an increasingly...
To view the full article, register now.